Lv61
2308 积分 2021-06-15 加入
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial
52分钟前
待确认
The Nuclear Face of PTEN: Implications in Cancer Prognosis and Targeted Therapy
25天前
已完结
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial
1个月前
已完结
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
1个月前
已完结
First-line lorlatinib treatment in a 19-year-old patient with ALK-rearranged pulmonary large-cell neuroendocrine carcinoma: a case report and literature review
1个月前
已完结
Integrated morphological, immunohistochemical, and genomic profiling identifies uterine leiomyoma patients with hereditary leiomyomatosis and renal cell cancer syndrome: a comprehensive analysis of 252 cases
2个月前
已完结
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
3个月前
已完结
Comparison of survival outcomes for patients with Lynch vs non‐Lynch syndrome and microsatellite unstable colorectal cancer treated with immunotherapy
3个月前
已完结
A phase 2 trial of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability (NCT02899793): Updated survival and response analyses
3个月前
已完结
第5版WHO造血与淋巴组织肿瘤分类组织细胞/树突细胞肿瘤及淋巴组织间质源性肿瘤解读
3个月前
已完结
皖公网安备34019202002308
